Smith & Nephew acquires grommet maker Tusker Medical
Tusker Medical has developed Tula System, a technology that allows children to receive the correct treatment for ear infections without undergoing surgery
Company
Smith & Nephew PLC
LON:SN.
Smith & Nephew develops advanced medical devices for healthcare professionals around the world
147 stories · page 4 of 8
Smith & Nephew replaces guidance for revenues and profit margins
The target for trading profit margins was trimmed due to dilution from acquisitions, currency headwinds and continued investment in the business
Smith & Nephew replaces CEO again
Chief executive Namal Nawana, who joined in May last year, will leave the artificial hip and knee company at the end of the month
Investments and investor services
Small-Cap Snapshot: Staffing company Insperity spikes on 4Q beat; Avaya plunges on 1Q sales miss
Also in play is a proposed merger between the UK's Smith & Nephew and US-based NuVasive Inc
Smith & Nephew slips on downgrade from JP Morgan Cazenove
Shares in the artificial joints maker performed well last year, but analysts reckon risk-reward is now “more balanced”
Morgan Stanley reckons new Smith & Nephew boss can “reinvigorate” artificial hip maker
“We upgrade to ‘overweight’ on the basis that, following several years of stagnation, new management should help reinvigorate top-line performance”
Smith & Nephew on track to deliver full-year guidance as third-quarter revenue rises thanks to strong demand in US, emerging markets
In a brief trading update, the FTSE 100-listed medical technology group said its third-quarter revenue was US$1.169bn, up 2% on a reported basis and 3% on an underlying basis
FTSE 100 closes lower as sterling gains on BoE rate comments
The bank suggested there could be a faster pace of hikes if the UK gets a smooth Brexit deal
Archive
No change expected from Bank of England on 'Super Thursday' despite Budget optimism
Aside from the BoE interest rate decision, the Day Ahead will also bring updates from the likes of BT Group, Royal Dutch Shell, Smith & Nephew, Shire, Just Eat, and Indivior
Smith & Nephew downgraded to 'hold' by HSBC as it awaits signs of a turnaround
"For Reconstruction (32% of sales) we anticipate an uptick in Knee (+4%) and Hip implants (+1.5%), rebounding from the soft start to the year that was affected by fewer elective surgeries in the US and UK," HSBC said
Investments and investor services
FTSE 100 closes firmly lower as trade fears, bond yields and sterling rise creates perfect storm
The Footsie closed down nearly 92 points at 7,418, while the other major European benchmarks were also lower.
Investments and investor services
DFS Furniture set to release full year results, have investors already heard the worst?
DFS and Electrocomponents are set to be among Thursday's highlights.
Archive
Jack’s store roll-out in focus as Tesco reports first half results
The week ahead includes Tesco interims, full-year earnings from DFS Furniture and Ferguson, an Electrocomponents trading update and the US non-farm payrolls report
UBS downgrades Smith & Nephew on surgical robot market concerns
UBS also sees a potential slowdown in Smith & Nephew's hip and knee market
New Smith & Nephew boss gives bullish assessment of artificial hip maker’s health
Namal Nawana’s upbeat comments came as Smith & Nephew reported a 4% rise in half-year revenue, confirmed its cost-cutting strategy is progressing well and reiterated full-year guidance
FTSE 100 keeps head above water at close: Facebook in focus
The Nasdaq on Wall Street is down over 88 points at the time of writing, at 7,420.
Archive
Blue-chip deluge on Thursday with Royal Dutch Shell, AstraZeneca and Diageo (and more) set to report
Three of the 10 largest London-listed companies (by capitalisation) are updating the market on Thursday. A dozen or more other household names are also expected to report.
Smith & Nephew shares rally slightly despite a Deutsche Bank downgrade after results disappointment
The German bank’s analysts cut their stance on the FTSE 100-listed artificial hips and knees maker to ‘sell’ from ‘hold’ and reduced their target price to 1,200p from 1.315p
Investments and investor services
Gloo Networks, Midatech Pharma and Anglo African Oil & Gas among Thursday’s small cap movers
A look at some of the biggest risers and fallers in London on Thursday.
Smith & Nephew cuts full year revenue guidance after weaker first quarter
Smith & Nephew said quarterly revenues were hit by one fewer trading day than last year, softer market conditions and a poor performance in the advanced wound bioactives business